Page 24 - Drugs Controller News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Madras High Court today issued a notice to the Centre on a petition to declare the Serum Institute's Covishield vaccine unsafe. The notice was issued in response to a writ petition filed by a Chennai-based business consultant who volunteered for the trial. He claims he suffered from side effects, for which he sought a compensation of Rs 5 crore. Legal team representing the Serum Institute said, "Allegations made in the petition are unfounded and frivolous. Serum will respond to same appropriately before the madras high court." In November 2020, the litigant sent a legal notice to Seru...

The company has "received Import and Market Permission in Form CT-20 (Subsequent New Drug Approval) from the DCGI for Dapagliflozin tablets 10 mg," AstraZeneca Pharma India said in a filing to BSE.

India News: An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vacc

Scientists, public health experts and opposition politicians have raised questions about one of the two vaccines the country of 1.4 billion people has authorized for emergency use against COVID-19.

India News: Serum Institute of India on Monday received a purchase order from the government for 11 million doses of Covishield vaccine developed by Oxford-AstraZ